GeneDx Holdings Corp. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2019 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
GeneDx Holdings Corp. annual/quarterly Net Cash Provided by (Used in) Financing Activities history and growth rate from 2019 to 2024.
  • GeneDx Holdings Corp. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was -$438K, a 100% decline year-over-year.
  • GeneDx Holdings Corp. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $44.2M, a 76.3% decline from 2023.
  • GeneDx Holdings Corp. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $186M, a 5.61% decline from 2022.
  • GeneDx Holdings Corp. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $197M, a 60% decline from 2021.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $44.2M -$142M -76.3% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-20
2023 $186M -$11.1M -5.61% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-20
2022 $197M -$296M -60% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-23
2021 $494M +$365M +283% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-16
2020 $129M -$19M -12.8% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-16
2019 $148M Jan 1, 2019 Dec 31, 2019 10-K 2022-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.